{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:26:40Z","timestamp":1787372800274,"version":"build-2736575974"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7887-26","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:10:59Z","timestamp":1787091059000},"source":"Crossref","is-referenced-by-count":0,"title":["Late-onset Human Herpesvirus 6 Encephalitis with Secondary Hemophagocytic Lymphohistiocytosis after CAR T-cell Therapy"],"prefix":"10.2169","author":[{"given":"Kyoko","family":"Masuda","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Sota","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aika","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Tanigawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Takikawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiho","family":"Tozuka","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Shindo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Fujii","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"},{"name":"Center for Transfusion Medicine and Cell Therapy, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Neurology, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ishizuchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Center for Transfusion Medicine and Cell Therapy, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Koda","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan"},{"name":"Division of Molecular Oncology, National Cancer Center Research Institute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Schuster SJ, Bishop MR, Tam CS, et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N Engl J Med 380: 45-56, 2019.","DOI":"10.1056\/NEJMoa1804980"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Abramson JS, Palomba ML, Gordon LI, et al. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. Lancet 396: 839-852, 2020.","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"3","unstructured":"3. Locke FL, Ghobadi A, Jacobson CA, et al. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial. Lancet Oncol 20: 31-42, 2019."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hill JA, Seo SK. How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies. Blood 136: 925-935, 2020.","DOI":"10.1182\/blood.2019004000"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. An J, Zhao J, Zou P, et al. Infections associated with CAR-T cell therapy in patients with relapsed refractory multiple myeloma: risks and prevention strategies. Cancer Med 13: e7372, 2024.","DOI":"10.1002\/cam4.7372"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kampouri E, Krantz EM, Xie H, et al. Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients. Blood 144: 490-495, 2024.","DOI":"10.1182\/blood.2024024145"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Isaac ST, Bishop DC, Shaikh F, et al. Human herpesvirus 6 viremia and encephalitis in CAR T-cell recipients. Blood 146: 3124-3128, 2025.","DOI":"10.1182\/blood.2025029057"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Omuro A, Correa DD, DeAngelis LM, et al. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood 125: 1403-1410, 2015.","DOI":"10.1182\/blood-2014-10-604561"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Henter J-I, Horne A, Aric\u00f3 M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48: 124-131, 2007.","DOI":"10.1002\/pbc.21039"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ogata M, Uchida N, Fukuda T, et al. Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant 55: 1004-1013, 2020.","DOI":"10.1038\/s41409-019-0752-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Baird JH, Epstein DJ, Tamaresis JS, et al. Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma. Blood Adv 5: 143-155, 2021.","DOI":"10.1182\/bloodadvances.2020002732"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Airosa Pardal A, Benzaqu\u00e9n A, Granados P, et al. Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma. HemaSphere 9: e70229, 2025.","DOI":"10.1002\/hem3.70229"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Luan D, DeWolf S, Fei T, et al. Dynamics of immune reconstitution and impact on outcomes across CAR-T cell products in large B-cell lymphoma. Blood Cancer Discov 6: 119-130, 2025.","DOI":"10.1158\/2643-3230.BCD-24-0163"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Brisse E, Matthys P, Wouters CH. Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol 174: 175-187, 2016.","DOI":"10.1111\/bjh.14144"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet 383: 1503-1516, 2014.","DOI":"10.1016\/S0140-6736(13)61048-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 38: 20-31, 2006.","DOI":"10.1080\/07853890500465189"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Brisse E, Wouters CH, Matthys P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br J Haematol 174: 203-217, 2016.","DOI":"10.1111\/bjh.14147"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rahman AU, Baig F, Javid Chaudhary UI, et al. Hemophagocytic lymphohistiocytosis associated with Human Herpesvirus-6 (HHV-6) infection in an immunocompetent adult: a case report. Cureus 16: e54299, 2024.","DOI":"10.7759\/cureus.54299"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chia XT, Wong HLM, Loh JS. Human herpesvirus-6 infection in a critically ill and immunocompetent patient: a case report. J Med Case Rep 18: 81, 2024.","DOI":"10.1186\/s13256-024-04387-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shyu S, Luca D, VandenBussche CJ, Ho C-Y. Cytomorphologic features found in cerebrospinal fluid specimens of hemophagocytic lymphohistiocytosis patients. Am J Clin Pathol 156: 381-390, 2021.","DOI":"10.1093\/ajcp\/aqaa248"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7887-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:10:49Z","timestamp":1787371849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7887-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7887-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7887-26"}}